Medikaloka Hermina (Indonesia) Market Value

HEAL Stock  IDR 1,505  5.00  0.33%   
Medikaloka Hermina's market value is the price at which a share of Medikaloka Hermina trades on a public exchange. It measures the collective expectations of Medikaloka Hermina PT investors about its performance. Medikaloka Hermina is selling for 1505.00 as of the 4th of December 2024. This is a 0.33 percent up since the beginning of the trading day. The stock's last reported lowest price was 1480.0.
With this module, you can estimate the performance of a buy and hold strategy of Medikaloka Hermina PT and determine expected loss or profit from investing in Medikaloka Hermina over a given investment horizon. Check out Medikaloka Hermina Correlation, Medikaloka Hermina Volatility and Medikaloka Hermina Alpha and Beta module to complement your research on Medikaloka Hermina.
Symbol

Please note, there is a significant difference between Medikaloka Hermina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medikaloka Hermina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medikaloka Hermina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Medikaloka Hermina 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medikaloka Hermina's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medikaloka Hermina.
0.00
11/04/2024
No Change 0.00  0.0 
In 31 days
12/04/2024
0.00
If you would invest  0.00  in Medikaloka Hermina on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding Medikaloka Hermina PT or generate 0.0% return on investment in Medikaloka Hermina over 30 days. Medikaloka Hermina is related to or competes with Surya Citra, Sawit Sumbermas, Mitra Pinasthika, Jakarta Int, Indosat Tbk, Inocycle Technology, and J Resources. PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia More

Medikaloka Hermina Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medikaloka Hermina's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medikaloka Hermina PT upside and downside potential and time the market with a certain degree of confidence.

Medikaloka Hermina Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Medikaloka Hermina's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medikaloka Hermina's standard deviation. In reality, there are many statistical measures that can use Medikaloka Hermina historical prices to predict the future Medikaloka Hermina's volatility.
Hype
Prediction
LowEstimatedHigh
1,5031,5051,507
Details
Intrinsic
Valuation
LowRealHigh
1,2321,2341,656
Details
Naive
Forecast
LowNextHigh
1,5881,5901,592
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,3721,4361,500
Details

Medikaloka Hermina Backtested Returns

Medikaloka Hermina appears to be very steady, given 3 months investment horizon. Medikaloka Hermina has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We have found thirty technical indicators for Medikaloka Hermina, which you can use to evaluate the volatility of the firm. Please exercise Medikaloka Hermina's Risk Adjusted Performance of 0.097, mean deviation of 1.49, and Downside Deviation of 1.71 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Medikaloka Hermina holds a performance score of 9. The company secures a Beta (Market Risk) of -0.35, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Medikaloka Hermina are expected to decrease at a much lower rate. During the bear market, Medikaloka Hermina is likely to outperform the market. Please check Medikaloka Hermina's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether Medikaloka Hermina's current price movements will revert.

Auto-correlation

    
  -0.79  

Almost perfect reverse predictability

Medikaloka Hermina PT has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Medikaloka Hermina time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medikaloka Hermina price movement. The serial correlation of -0.79 indicates that around 79.0% of current Medikaloka Hermina price fluctuation can be explain by its past prices.
Correlation Coefficient-0.79
Spearman Rank Test-0.88
Residual Average0.0
Price Variance4030.99

Medikaloka Hermina lagged returns against current returns

Autocorrelation, which is Medikaloka Hermina stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medikaloka Hermina's stock expected returns. We can calculate the autocorrelation of Medikaloka Hermina returns to help us make a trade decision. For example, suppose you find that Medikaloka Hermina has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Medikaloka Hermina regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medikaloka Hermina stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medikaloka Hermina stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medikaloka Hermina stock over time.
   Current vs Lagged Prices   
       Timeline  

Medikaloka Hermina Lagged Returns

When evaluating Medikaloka Hermina's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medikaloka Hermina stock have on its future price. Medikaloka Hermina autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medikaloka Hermina autocorrelation shows the relationship between Medikaloka Hermina stock current value and its past values and can show if there is a momentum factor associated with investing in Medikaloka Hermina PT.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Medikaloka Stock

Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.